Generating more (political) attention and awareness about the cardiovascular disease burden in order to gain support for measures aimed at our partners’ collaborative goals for prevention, early recognition and better treatment for cardiovascular diseases. Public Affairs and Communication complement each other and therefore collaborate within a single strategic pillar. The pillar supports alignment between partners, enhances internal communication between partner organisations, and acts as coordinator for collaborative advocacy. Together, the DCVA will voice and amplify the voice of the Partners for political awareness and actions to reach our aims.
Externally, we work together with all partners to prioritize cardiovascular diseases as an urgent public health issue on the Dutch political agenda. We aim for political accountability, alongside stakeholders, in reducing the burden of cardiovascular diseases. This requires broad support to implement effective measures and calls for effective communication.
Internally, we enhance connections among researchers and between researchers and other stakeholders in the knowledge-to-action chain, facilitating natural and effective collaboration. In our communications, we strive to enhance partner collaboration within DCVA and showcase their engagement in various initiatives.
This working group comes together every 2-3 months to discuss ongoing issues and opportunities. Partners represented in this working group are: Harteraad, Hartstichting, NeFeMED, NLHI, NHR, Nierstichting, NVIVG, NVvC, NVvR, Stichting Hartekind, VIG
This working group comes together 2x per year to adress issues that concern collaborative communication. Partners represented in this working group are: Harteraad, Hartstichting, NHR, Nierstichting, Stichting Hartekind, ZonMw
Professor Jolien Roos-Hesselink is a distinguished cardiologist and researcher, known for her expertise in congenital heart disease and her contributions to advancing cardiovascular care. With affiliations at the Erasmus Medical Center Rotterdam and Radboud University Medical Center Nijmegen, she has been appointed as the managing-director of the DCVA in 2022.
